Can pressurized oxygen boost cord blood transplants?

NCT ID NCT03739502

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether giving patients hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) after an umbilical cord blood stem cell transplant helps the donated stem cells grow faster. The trial enrolls people with blood cancers like leukemia or lymphoma who lack a matched donor. The goal is to see if this approach shortens the time to immune recovery and reduces complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hyperbaric oxygen therapy
What this could lead to
If it works, this could speed up recovery of the immune system after cord blood transplants, reducing infection risk and hospital stays.
What could go wrong
This is a small, early-phase study, so results may not be conclusive. Hyperbaric oxygen can cause ear or sinus discomfort and, rarely, lung issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Rochester

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.